Cargando…

Interplay between Caveolin-1 and body and tumor size affects clinical outcomes in breast cancer

BACKGROUND: Caveolin-1 (CAV1) is associated with cholesterol-rich membrane raft domains and is a master regulator of cell signaling and membrane transport. Here, we investigated CAV1’s role in cellular compartments of breast cancer in relation to signaling pathways, clinicopathological features, and...

Descripción completa

Detalles Bibliográficos
Autores principales:	Godina, Christopher, Indira Chandran, Vineesh, Barbachowska, Magdalena, Tryggvadottir, Helga, Nodin, Björn, Visse, Edward, Borgquist, Signe, Jirström, Karin, Isaksson, Karolin, Bosch, Ana, Belting, Mattias, Jernström, Helena
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Neoplasia Press 2022
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9166433/ https://www.ncbi.nlm.nih.gov/pubmed/35660849 http://dx.doi.org/10.1016/j.tranon.2022.101464

Ejemplares similares

Caveolin-1 genotypes as predictor for locoregional recurrence and contralateral disease in breast cancer
por: Godina, Christopher, et al.
Publicado: (2023)

Prognostic impact of tumor-specific insulin-like growth factor binding protein 7 (IGFBP7) levels in breast cancer: a prospective cohort study
por: Godina, Christopher, et al.
Publicado: (2021)

Patient Characteristics Influence Activated Signal Transducer and Activator of Transcription 3 (STAT3) Levels in Primary Breast Cancer—Impact on Prognosis
por: Nilsson, Linn, et al.
Publicado: (2020)

Prognostic Impact of Menopausal Hormone Therapy in Breast Cancer Differs According to Tumor Characteristics and Treatment
por: Godina, Christopher, et al.
Publicado: (2020)

Re-evaluation of HER2 status in 606 breast cancers—gene protein assay on tissue microarrays versus routine pathological assessment
por: Sandén, Emma, et al.
Publicado: (2020)

CYP27A1 expression is associated with risk of late lethal estrogen receptor-positive breast cancer in postmenopausal patients
por: Kimbung, Siker, et al.
Publicado: (2020)

The Prognostic Impact of Intratumoral Aryl Hydrocarbon Receptor in Primary Breast Cancer Depends on the Type of Endocrine Therapy: A Population-Based Cohort Study
por: Tryggvadottir, Helga, et al.
Publicado: (2021)

Tumor-specific expression of HMG-CoA reductase in a population-based cohort of breast cancer patients
por: Gustbée, Emma, et al.
Publicado: (2015)

Impact of combining vitamin C with radiation therapy in human breast cancer: does it matter?
por: Khazaei, Somayeh, et al.
Publicado: (2022)

Coffee Is Associated With Lower Breast Tumor Insulin-Like Growth Factor Receptor 1 Levels in Normal-Weight Patients and Improved Prognosis Following Tamoxifen or Radiotherapy Treatment
por: Björner, Sofie, et al.
Publicado: (2018)

Interactions Between ABCB1 Genotype and Preoperative Statin Use Impact Clinical Outcomes Among Breast Cancer Patients
por: Tryggvadottir, Helga, et al.
Publicado: (2018)

Increasing preoperative body size in breast cancer patients between 2002 and 2016: implications for prognosis
por: Wisse, Agatha, et al.
Publicado: (2018)

Influence of anthropometric factors on tumour biological characteristics of colorectal cancer in men and women: a cohort study
por: Brändstedt, Jenny, et al.
Publicado: (2013)

HMG-CoA reductase expression in primary colorectal cancer correlates with favourable clinicopathological characteristics and an improved clinical outcome
por: Bengtsson, Erik, et al.
Publicado: (2014)

Androgen receptor expression and breast cancer mortality in a population-based prospective cohort
por: Elebro, Karin, et al.
Publicado: (2017)

Body Mass Index Influences the Prognostic Impact of Combined Nuclear Insulin Receptor and Estrogen Receptor Expression in Primary Breast Cancer
por: Björner, Sofie, et al.
Publicado: (2017)

Combined and individual tumor-specific expression of insulin-like growth factor-I receptor, insulin receptor and phospho-insulin-like growth factor-I receptor/insulin receptor in primary breast cancer: Implications for prognosis in different treatment groups
por: Björner, Sofie, et al.
Publicado: (2016)

Pre- and Postoperative Circulating IGF-I, IGFBP-3, and IGFBP-7 Levels in Relation to Endocrine Treatment and Breast Cancer Recurrence: A Nested Case-Control Study
por: Rosendahl, Ann H., et al.
Publicado: (2021)

Hormonal factors and pancreatic cancer risk in women: The Malmö Diet and Cancer Study
por: Andersson, Gustav, et al.
Publicado: (2018)

Tumor antigen glycosaminoglycan modification regulates antibody-drug conjugate delivery and cytotoxicity
por: Christianson, Helena C., et al.
Publicado: (2017)

Endogenous incretin levels and risk of first incident cancer: a prospective cohort study
por: Jujić, Amra, et al.
Publicado: (2023)

Statin use and patterns of breast cancer recurrence in the Malmö Diet and Cancer Study
por: Inasu, Maria, et al.
Publicado: (2022)

Pancreatic cancer risk in relation to sex, lifestyle factors, and pre-diagnostic anthropometry in the Malmö Diet and Cancer Study
por: Andersson, Gustav, et al.
Publicado: (2016)

Global extracellular vesicle proteomic signature defines U87-MG glioma cell hypoxic status with potential implications for non-invasive diagnostics
por: Indira Chandran, Vineesh, et al.
Publicado: (2019)

Hypoxia regulates global membrane protein endocytosis through caveolin-1 in cancer cells
por: Bourseau-Guilmain, E., et al.
Publicado: (2016)

Discovery of dachshund 2 protein as a novel biomarker of poor prognosis in epithelial ovarian cancer
por: Nodin, Björn, et al.
Publicado: (2012)

Clinicopathological correlates and prognostic significance of KRAS mutation status in a pooled prospective cohort of epithelial ovarian cancer
por: Nodin, Björn, et al.
Publicado: (2013)

Expression of the global regulator SATB1 is an independent factor of poor prognosis in high grade epithelial ovarian cancer
por: Nodin, Björn, et al.
Publicado: (2012)

The effect of statin treatment on intratumoral cholesterol levels and LDL receptor expression: a window-of-opportunity breast cancer trial
por: Feldt, Maria, et al.
Publicado: (2020)

Clinical impact of T cells, B cells and the PD-1/PD-L1 pathway in muscle invasive bladder cancer: a comparative study of transurethral resection and cystectomy specimens
por: Wahlin, Sara, et al.
Publicado: (2019)

Local Biomarkers Involved in the Interplay between Obesity and Breast Cancer
por: Holm, Jonas Busk, et al.
Publicado: (2021)

Modifying effect of gender on the prognostic value of clinicopathological factors and Ki67 expression in melanoma: a population-based cohort study
por: Fridberg, Marie, et al.
Publicado: (2012)

Prognostic and predictive significance of podocalyxin-like protein expression in pancreatic and periampullary adenocarcinoma
por: Heby, Margareta, et al.
Publicado: (2015)

Prognostic impact of tumour-associated B cells and plasma cells in epithelial ovarian cancer
por: Lundgren, Sebastian, et al.
Publicado: (2016)

Prognostic impact of tumour-specific HMG-CoA reductase expression in primary breast cancer
por: Borgquist, Signe, et al.
Publicado: (2008)

Exosome Uptake Depends on ERK1/2-Heat Shock Protein 27 Signaling and Lipid Raft-mediated Endocytosis Negatively Regulated by Caveolin-1
por: Svensson, Katrin J., et al.
Publicado: (2013)

Expression of programmed cell death protein 1 (PD-1) and its ligand PD-L1 in colorectal cancer: Relationship with sidedness and prognosis
por: Berntsson, Jonna, et al.
Publicado: (2018)

Pre-diagnostic anthropometry, sex, and risk of colorectal cancer according to tumor immune cell composition
por: Berntsson, Jonna, et al.
Publicado: (2019)

Cyclin D1 expression in colorectal cancer is a favorable prognostic factor in men but not in women in a prospective, population-based cohort study
por: Wangefjord, Sakarias, et al.
Publicado: (2011)

High MCM3 expression is an independent biomarker of poor prognosis and correlates with reduced RBM3 expression in a prospective cohort of malignant melanoma
por: Nodin, Björn, et al.
Publicado: (2012)

Cannot write session to /tmp/vufind_sessions/sess_ddmtilf23bktcp65ta2nedi41o